WEST ALLIS — Johnson Creek senior Luke Hartz placed fourth at 157 pounds to lead the Bluejays to a 13th place finish at the ...

Pop icon Taylor Swift recently had a surprise for an unsuspecting Arrowhead Stadium worker by splurging out a generous $600 ...

If Thursday night was the last game Travis Kelce played inside Arrowhead Stadium, he sure tried to make it a memorable one.

The days between Christmas and New Year’s Day are among the most exciting of the high school sports winter season. That’s because many of the Inland area’s best basketball, wrestling and soccer teams ...

With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm. Complicating the matter, however, is the fact ...

The Kansas City Chiefs have been one of the NFL’s most dominant teams of the last decade, winning three Super Bowl championships and playing in seven straight AFC Championship games. And while the ...

Arrowhead Pharmaceuticals has seen its consensus analyst price target increase from $45 to $47.50 per share, reflecting growing confidence in the company's strategy and market positioning. This ...

Among the quiet pines above Lake Arrowhead, a battle is underway, one that will decide who calls the shots in the unincorporated community nestled in the San Bernardino Mountains. In 1915, property ...

Muskego's defense secured a 21-17 victory over Arrowhead with a game-saving interception in the final seconds. The Muskego defense made three crucial stops inside the red zone during the second half.

Pasadena-based Arrowhead Pharmaceuticals Inc. has announced another major licensing deal with a pharma giant. This one is with Basel, Switzerland-based Novartis for $200 million in upfront payment and ...

Sept 11 (Reuters) - Ionis Pharmaceuticals (IONS.O), opens new tab sued biotech rival Arrowhead Pharmaceuticals (ARWR.O), opens new tab for patent infringement in California federal court on Thursday ...

Arrowhead Pharmaceuticals has launched legal action against Ionis Pharmaceuticals, aiming to neutralize Ionis' claim that Arrowhead's potential rival to Tryngolza breaches a patent. Arrowhead claims ...